CORDIS
EU research results

CORDIS

English EN
Ocular Research By Integrated Training And Learning

Ocular Research By Integrated Training And Learning

Objective

Diseases of the posterior segment of the eye are increasing considerably, partly due to an ageing population
(almost 20% of the population of Europe now over 65). Despite accounting for approximately 55% of ocular conditions,
only 5% of ocular product sales target the posterior segment due to the technical difficulties in developing safe, effective
and easy-to-use formulations. Age-related Macular Degeneration and Diabetic retinopathy are some of the main cause
of blindness and severe impairment of vision in patients. These diseases represent a considerable burden on
patients and healthcare systems throughout the world. ORBITAL has the primary objective of recruiting excellent early
stage researchers (ESRs) and developing the next generation of research leaders and drivers. There is a clear unmet
clinical need for efficient, safe, non-invasive and patient-friendly strategies for the treatment of prevalent diseases of
the posterior segment of the eye. With a necessary collaborative network of European and global experts, from
academic, clinical and industrial sectors, ESRs will be exposed to an integrated and complementary network of
expertise in materials science, nanotechnology, animal modeling, enhanced in-vitro testing, analytical chemistry and
drug discovery. ORBITAL will build an intersectoral consortium with extensive experience in generating innovative technologies and training new researchers. ESRs will be exposed to a broad scientific landscape of complementary
disciplines. With the combined skills and knowledge of the consortium, ESRs will be provided with the network, skills
and knowledge to develop their careers while the extensive mobility of researchers will lead to increased knowledge
transfer and collaborative research

Coordinator

WATERFORD INSTITUTE OF TECHNOLOGY

Address

Cork Road
X91 Waterford

Ireland

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 824 052,96

Participants (10)

Sort alphabetically

Sort by EU Contribution

Expand all

UNIVERSIDAD DE SANTIAGO DE COMPOSTELA

Spain

EU Contribution

€ 501 809,76

THE QUEEN'S UNIVERSITY OF BELFAST

United Kingdom

EU Contribution

€ 606 345,12

INSTITUTO SUPERIOR TECNICO

Portugal

EU Contribution

€ 237 720,24

HASKOLI ISLANDS

Iceland

EU Contribution

€ 274 331,16

THE UNIVERSITY OF BIRMINGHAM

United Kingdom

EU Contribution

€ 303 172,56

UNIVERSIDAD COMPLUTENSE DE MADRID

Spain

EU Contribution

€ 250 904,88

EXPERIMENTICA OY

Finland

EU Contribution

€ 280 805,76

NANOVECTOR SRL

Italy

EU Contribution

€ 261 499,68

UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN

Ireland

EU Contribution

€ 274 684,32

OCUPHARM DIAGNOSTICS SL

Spain

EU Contribution

€ 250 904,88

Partners (11)

Sort alphabetically

Expand all

Hospital das Forças Armadas (HFAR) - EMGFA

Fighting Blindness

The Vision Clinic

OcuMedic Inc.

UNIVERSITA DEGLI STUDI DI PARMA

University of Waterloo

Loyola University Stritch School of Medicine

University of Florida

Rowan University

HGBEYOND MATERIALS SICENCE SL

NEUREGENIX LIMITED

Project information

Grant agreement ID: 813440

Status

Grant agreement signed

  • Start date

    1 September 2019

  • End date

    31 August 2023

Funded under:

H2020-EU.1.3.1.

  • Overall budget:

    € 4 066 231,32

  • EU contribution

    € 4 066 231,32

Coordinated by:

WATERFORD INSTITUTE OF TECHNOLOGY

Ireland